Introducing pharmacogenomic decision support for medication risk assessment in people with polypharmacy

Polypharmacy has been shown to be a source of multiple adverse drug events. Recent studies demonstrated that pharmacogenomic testing may be instrumental in optimizing medication regimen. However, majority of current pharmacogenomic decision support tools provide assessment only of single drug-gene i...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) S. 1803 - 1808
Hauptverfasser:	Jiazhen Liu, Finkelstein, Joseph
Format:	Tagungsbericht
Sprache:	Englisch
Veröffentlicht:	IEEE 01.11.2017
Schlagworte:	Additives adverse drug events Biochemistry decision support Drugs Genetics Inhibitors pharmacogenomics polypharmacy Substrates
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!